Myomo Q2 Earnings Call Highlights
· finance.yahoo.com
Myomo (NYSEAMERICAN:MYO) reported second-quarter 2026 revenue growth of 21% as the wearable robotics company continued shifting its patient acquisition strategy toward recurring referral sources and expanded reimbursement relationships. Revenue for the quarter totaled $11.7 million, compared with t
Within recurring channels, direct-billing referrals through the MyoConnect program accounted for 23% of total revenue, up from 20% in the first quarter. Interna...